Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Prospective, Longitudinal Study of YKL-40 in Patients With FIGO Stage III or IV Invasive Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer Undergoing Primary Chemotherapy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00899093
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:54.818900+00:00
Published At
2018-05-22T00:00:00+00:00
Record Updated At
2018-05-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Fallopian Tube Adenocarcinoma", "Fallopian Tube Clear Cell Adenocarcinoma", "Fallopian Tube Endometrioid Adenocarcinoma", "Fallopian Tube Mucinous Adenocarcinoma", "Fallopian Tube Serous Adenocarcinoma", "Fallopian Tube Transitional Cell Carcinoma", "Malignant Ovarian Brenner Tumor", "Malignant Ovarian Clear Cell Tumor", "Malignant Ovarian Endometrioid Tumor", "Malignant Ovarian Mixed Epithelial Tumor", "Malignant Ovarian Mucinous Tumor", "Malignant Ovarian Neoplasm", "Malignant Ovarian Serous Tumor", "Malignant Ovarian Transitional Cell Tumor", "Ovarian Adenocarcinoma", "Primary Peritoneal Serous Adenocarcinoma", "Stage IIIA Fallopian Tube Cancer", "Stage IIIA Ovarian Cancer", "Stage IIIA Primary Peritoneal Cancer", "Stage IIIB Fallopian Tube Cancer", "Stage IIIB Ovarian Cancer", "Stage IIIB Primary Peritoneal Cancer", "Stage IIIC Fallopian Tube Cancer", "Stage IIIC Ovarian Cancer", "Stage IIIC Primary Peritoneal Cancer", "Stage IV Fallopian Tube Cancer", "Stage IV Ovarian Cancer", "Stage IV Primary Peritoneal Cancer", "Undifferentiated Fallopian Tube Carcinoma", "Undifferentiated Ovarian Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-05-22"
protocolSection.identificationModule.nctId
"NCT00899093"
protocolSection.identificationModule.officialTitle
"A Prospective, Longitudinal Study of YKL-40 in Patients With FIGO Stage III or IV Invasive Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer Undergoing Primary Chemotherapy"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Fallopian Tube Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Fallopian Tube Clear Cell Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Fallopian Tube Endometrioid Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Fallopian Tube Mucinous Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Fallopian Tube Serous Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Fallopian Tube Transitional Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Malignant Ovarian Brenner Tumor (protocolSection.conditionsModule.conditions)
  • Malignant Ovarian Clear Cell Tumor (protocolSection.conditionsModule.conditions)
  • Malignant Ovarian Endometrioid Tumor (protocolSection.conditionsModule.conditions)
  • Malignant Ovarian Mixed Epithelial Tumor (protocolSection.conditionsModule.conditions)
  • Malignant Ovarian Mucinous Tumor (protocolSection.conditionsModule.conditions)
  • Malignant Ovarian Neoplasm (protocolSection.conditionsModule.conditions)
  • Malignant Ovarian Serous Tumor (protocolSection.conditionsModule.conditions)
  • Malignant Ovarian Transitional Cell Tumor (protocolSection.conditionsModule.conditions)
  • Ovarian Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Primary Peritoneal Serous Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage IIIA Fallopian Tube Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Ovarian Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Primary Peritoneal Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIB Fallopian Tube Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIB Ovarian Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIB Primary Peritoneal Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIC Fallopian Tube Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIC Ovarian Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIC Primary Peritoneal Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Fallopian Tube Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Ovarian Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Primary Peritoneal Cancer (protocolSection.conditionsModule.conditions)
  • Undifferentiated Fallopian Tube Carcinoma (protocolSection.conditionsModule.conditions)
  • Undifferentiated Ovarian Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.